These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 31129792)

  • 1. Whole blood viscosity in systemic sclerosis: a potential biomarker of pulmonary hypertension?
    Senturk B; Akdeniz B; Yilmaz MB; Ozcan Kahraman B; Acar B; Uslu S; Birlik M
    Clin Rheumatol; 2020 Jan; 39(1):49-56. PubMed ID: 31129792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Contribution of Whole Blood Viscosity to the Process of Aortic Valve Sclerosis.
    Sercelik A; Besnili AF
    Med Princ Pract; 2018; 27(2):173-178. PubMed ID: 29421801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Forgotten Variable of Shear Stress in Mitral Annular Calcification: Whole Blood Viscosity.
    Ozcan Cetin EH; Cetin MS; Canpolat U; Kalender E; Topaloglu S; Aras D; Aydogdu S
    Med Princ Pract; 2015; 24(5):444-50. PubMed ID: 26159574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.
    Thakkar V; Stevens WM; Prior D; Moore OA; Byron J; Liew D; Patterson K; Hissaria P; Roddy J; Zochling J; Sahhar J; Nash P; Tymms K; Celermajer D; Gabbay E; Youssef P; Proudman SM; Nikpour M
    Arthritis Res Ther; 2012 Jun; 14(3):R143. PubMed ID: 22691291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.
    Thakkar V; Stevens W; Prior D; Rabusa C; Sahhar J; Walker JG; Roddy J; Lester S; Rischmueller M; Zochling J; Nash P; Gabbay E; Youssef P; Proudman SM; Nikpour M
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):129-136. PubMed ID: 27214686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Whole Blood Viscosity in Patients with Aortic Sclerosis.
    Duyuler PT; Duyuler S; İleri M; Demir M; Dolu AK; Başyiğit F
    J Tehran Heart Cent; 2017 Jan; 12(1):6-10. PubMed ID: 28469685
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of whole blood viscosity with thrombus presence in patients undergoing transoesophageal echocardiography.
    Çınar T; Hayıroğlu Mİ; Selçuk M; Çiçek V; Doğan S; Kılıç Ş; Yavuz S; Babaoğlu M; Uzun M; Orhan AL
    Int J Cardiovasc Imaging; 2022 Mar; 38(3):601-607. PubMed ID: 34655000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial injury assessed with functional techniques in systemic sclerosis patients with pulmonary arterial hypertension versus systemic sclerosis patients without pulmonary arterial hypertension: a systematic review and meta-analysis.
    Theodorakopoulou MP; Minopoulou I; Sarafidis P; Kamperidis V; Papadopoulos C; Dimitroulas T; Boutou AK
    Rheumatol Int; 2021 Jun; 41(6):1045-1053. PubMed ID: 33830321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between serological biomarkers of extracellular matrix turnover and lung fibrosis and pulmonary artery hypertension in patients with systemic sclerosis.
    Kubo S; Siebuhr AS; Bay-Jensen AC; Juhl P; Karsdal MA; Satoh Y; Todoroki Y; Nakano K; Nakayamada S; Tanaka Y
    Int J Rheum Dis; 2020 Apr; 23(4):532-539. PubMed ID: 32022479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The soluble receptor for advanced glycation end products is potentially predictive of pulmonary arterial hypertension in systemic sclerosis.
    Atzeni IM; Al-Adwi Y; Doornbos-van der Meer B; Roozendaal C; Stel A; van Goor H; Gan CT; Dickinson M; Timens W; Smit AJ; Westra J; Mulder DJ
    Front Immunol; 2023; 14():1189257. PubMed ID: 37409127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic peptide predicts disease progression and digital ulcers development in systemic sclerosis patients.
    Romaniello A; Rubattu S; Gigante A; Simonelli F; Grimaldi MC; D'Angelo A; Alunni D; Sada L; Gasperini ML; Marchitti S; Volpe M; Rosato E
    J Cardiovasc Med (Hagerstown); 2019 Nov; 20(11):771-779. PubMed ID: 31397686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Lymphangiogenic Factors With Pulmonary Arterial Hypertension in Systemic Sclerosis.
    Didriksen H; Molberg Ø; Fretheim H; Gude E; Jordan S; Brunborg C; Palchevskiy V; Garen T; Midtvedt Ø; Andreassen AK; Distler O; Belperio J; Hoffmann-Vold AM
    Arthritis Rheumatol; 2021 Jul; 73(7):1277-1287. PubMed ID: 33497027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension.
    Di Benedetto P; Guggino G; Manzi G; Ruscitti P; Berardicurti O; Panzera N; Grazia N; Badagliacca R; Riccieri V; Vizza CD; Radchenko G; Liakouli V; Ciccia F; Cipriani P; Giacomelli R
    Arthritis Res Ther; 2020 Jun; 22(1):127. PubMed ID: 32487240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCL21 as a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis.
    Hoffmann-Vold AM; Hesselstrand R; Fretheim H; Ueland T; Andreassen AK; Brunborg C; Palchevskiy V; Midtvedt Ø; Garen T; Aukrust P; Belperio JA; Molberg Ø
    Arthritis Rheumatol; 2018 Oct; 70(10):1644-1653. PubMed ID: 29687634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant long-chain fatty acid metabolism associated with evolving systemic sclerosis-associated pulmonary arterial hypertension.
    Coursen JC; Tuhy T; Naranjo M; Woods A; Hummers LK; Shah AA; Suresh K; Visovatti SH; Mathai SC; Hassoun PM; Damico RL; Simpson CE
    Am J Physiol Lung Cell Mol Physiol; 2024 Jul; 327(1):L54-L64. PubMed ID: 38651694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis.
    Rice LM; Mantero JC; Stratton EA; Warburton R; Roberts K; Hill N; Simms RW; Domsic R; Farber HW; Layfatis R
    Arthritis Res Ther; 2018 Aug; 20(1):185. PubMed ID: 30115106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral microvascular function is linked to cardiac involvement on cardiovascular magnetic resonance in systemic sclerosis-related pulmonary arterial hypertension.
    Vos JL; Lemmers JMJ; El Messaoudi S; Snoeren M; van Dijk APJ; Duijnhouwer AL; Rodwell L; van Leuven SI; Post MC; Vonk MC; Nijveldt R
    Eur Heart J Cardiovasc Imaging; 2024 Apr; 25(5):708-717. PubMed ID: 38170546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can whole blood viscosity predict the development of acute mesenteric arterial thrombosis?
    Gul S; Kucuk GO
    Ulus Travma Acil Cerrahi Derg; 2023 Jun; 29(6):685-690. PubMed ID: 37278073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysis.
    Sanges S; Rice L; Tu L; Valenzi E; Cracowski JL; Montani D; Mantero JC; Ternynck C; Marot G; Bujor AM; Hachulla E; Launay D; Humbert M; Guignabert C; Lafyatis R
    Ann Rheum Dis; 2023 Mar; 82(3):365-373. PubMed ID: 36600187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cell distribution width as a related factor of pulmonary arterial hypertension in patients with systemic sclerosis.
    Zhao J; Mo H; Guo X; Wang Q; Xu D; Hou Y; Tian Z; Liu Y; Wang H; Lai J; Li M; Zeng X
    Clin Rheumatol; 2018 Apr; 37(4):979-985. PubMed ID: 29164429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.